These final results, together with a earlier report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 guidance the concept of concentrating on ACKR3 as a novel strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-associated Ailments.A exploration review pub